臨床試驗

CIRSE Registry for SIR-Spheres in France (CIRT-FR)

NCT：NCT03256994 · COMPLETED

NCT IDNCT03256994

狀態COMPLETED

開始日期2017-08-01

完成時間2022-07-31

SponsorCardiovascular and Interventional Radiological Society of Europe (OTHER)

First posted2017-08-22

Last updated2026-05-13

簡要摘要

Selective Internal Radiation Therapy (SIRT), also known as radioembolisation, is a minimal invasive, endovascular treatment for primary and secondary liver tumours. In France, SIR-Spheres are listed as reimbursable by the national health authorities (Haute Autorité de Santé \[HAS\]). In order to evaluate the reimbursement after five years, all patients treated with SIR-Spheres will be entered into a registry that collects data on the real-life clinical application of SIRT and reports to the national authorities.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。